Objective -To assess and compare cognitive levels and proÀ les of À ve cognitive functions according to hypertensive and heart failure status. A subgroup analysis on 60-75 years old patients, 41 hypertensive, 19 heart failure and 33 normotensive patients matched on age, years of education and gender, was performed. No signiÀ cant difference on depression index, exposure to anxiolytics/hypnotics, sleep-apnea syndrome and other cardiovascular risk factors was observed. The cognitive proÀ le (Fig 1) shows signiÀ cant level differences between functions in heart failure compared to normotensive (normalized) with signiÀ cant deÀ cits in executive functions (p<0.01) and delayed memory (p<0.02), while cognitive functions are affected with the same level in hypertension except for recent memory.
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Methods
Conclusion -We conÀ rm that heart failure is an independent predictor of cognitive impairment, and affects more speciÀ cally language, executive functions, recent and delayed memory. Hypertension slightly impairs cognitive functions with the same level. In humans, TBX1 is the major candidate gene for DiGeorge (del22q11.2) syndrome, which includes heart malformations such as tetralogy of Fallot and Persistent Truncus Arteriosus (PTA). In Tbx1 null embryos, Second Heart Field (SHF) cardiac progenitor cell numbers are decreased leading to a hypoplastic outÁ ow tract and PTA. Recently, we have shown that the Tbx1 phenotype is associated with reduction of a speciÀ c progenitor cell population that normally contributes to myocardium at the base of the pulmonary trunk. The Tbx1 mutant ventricular outlet thus has a predominantly subaortic identity supported by the presence of a single outÁ ow valve with three leaÁ ets. In addition, we demonstrated that coronary artery patterning is abnormal in Tbx1-nulls. Proximal coronary arteries course abnormally across the ventral region of mutant hearts and left and right arteries branch to the right/ ventral sinus of the common outlet.
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INSIGHTS INTO THE GENETIC AND CELLULAR
Coronary artery patterning defects are observed at early developmental stages at the level of the coronary plexus suggesting that SHF derived cells inÁ uence the cellular and molecular events responsible for the distribution and branching of proximal coronary arteries. We have identiÀ ed Semaphorin3c as a Tbx1-dependent gene expressed in subpulmonary myocardium. However, Sema3c-null embryos do not show major coronary artery defects suggesting that Sema3c function overlaps with that of other genes affected in Tbx1 mutant embryos. We are now investigating the distribution and patterning of additional vascular guidance molecules as well as the distribution of neural crest cells and cardiac cushions which play critical roles in outÁ ow tract development in wild type mice.
Our results provide new insights into the association between conotruncal defects and coronary artery anomalies and implicate SHF derived cells in coronary artery patterning. Ongoing research in collaboration with Necker Hospital (Paris) aims to investigate whether speciÀ c coronary artery anomalies are associated with PTA in DiGeorge syndrome. 
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L'ALTÉRATION CONTRACTILE SOUS-ENDOCARDIQUE EST PRÉSENTE DANS UN MODÈLE CANIN DE DYSTROPHIE MUSCULAIRE DE DUCHENNE ET APPARAÎT COMME UN PHÉNOMÈNE CELLULAIRE INTRINSÈQUE
